Zobrazeno 51 - 60
of 449
pro vyhledávání: '"Sai-Hong Ignatius Ou"'
Autor:
Justin F. Gainor, Alexander Drilon, Aaron N. Hata, Sai-Hong Ignatius Ou, Michael S. Lawrence, Alice T. Shaw, Jochen K. Lennerz, Beow Y. Yeap, Lecia V. Sequist, Jennifer S. Temel, Christina J. Falcon, Adam J. Schoenfeld, Adam Langenbucher, Harper G. Hubbeling, Wafa Malik, Kylie Prutisto-Chang, Jennifer Peterson, Andrew Do, Charlotte Lee, Subba R. Digumarthy, Ibiayi Dagogo-Jack, Ramin Sakhtemani, Ted W. Johnson, Viola W. Zhu, Satoshi Yoda, Noura J. Choudhury, Jessica J. Lin
Supplementary Tables 1-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5b19d00684fec600f7f9f19f325d89
https://doi.org/10.1158/1078-0432.22478825
https://doi.org/10.1158/1078-0432.22478825
Autor:
Sai-Hong Ignatius Ou, Pasi A. Jänne, Takashi Seto, Yanfei Gao, Qinying Zhao, Frank Fan, Meijing Li, Chenhui Deng, Kenji Nakamaru, Takeshi Isoyama, Masaya Tachibana, Hiroyuki Hanzawa, Naoki Nakao, Giorgio Senaldi, Alexa B. Schrock, Russell Madison, Heather A. Wakelee, Thomas Yang Sun, Viola W. Zhu, Yuki Shimizu, Ryohei Katayama, Alice T. Shaw, Erkut Borazanci, Kyriakos P. Papadopoulos
Purpose:Taletrectinib (DS-6051b/AB-106) is an oral, tyrosine kinase inhibitor of ROS1 and NTRK with potent preclinical activity against ROS1 G2032R solvent-front mutation among others. We report the first-in-human U.S. phase I results of taletrectini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c0fc1994ca625c18ce962fd334f7b3a
https://doi.org/10.1158/1078-0432.c.6529236.v1
https://doi.org/10.1158/1078-0432.c.6529236.v1
Autor:
Justin F. Gainor, Alexander Drilon, Aaron N. Hata, Sai-Hong Ignatius Ou, Michael S. Lawrence, Alice T. Shaw, Jochen K. Lennerz, Beow Y. Yeap, Lecia V. Sequist, Jennifer S. Temel, Christina J. Falcon, Adam J. Schoenfeld, Adam Langenbucher, Harper G. Hubbeling, Wafa Malik, Kylie Prutisto-Chang, Jennifer Peterson, Andrew Do, Charlotte Lee, Subba R. Digumarthy, Ibiayi Dagogo-Jack, Ramin Sakhtemani, Ted W. Johnson, Viola W. Zhu, Satoshi Yoda, Noura J. Choudhury, Jessica J. Lin
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9ca50fde65b62aaec84f5f254dafcb
https://doi.org/10.1158/1078-0432.22478831.v1
https://doi.org/10.1158/1078-0432.22478831.v1
Autor:
Sai-Hong Ignatius Ou, Pasi A. Jänne, Takashi Seto, Yanfei Gao, Qinying Zhao, Frank Fan, Meijing Li, Chenhui Deng, Kenji Nakamaru, Takeshi Isoyama, Masaya Tachibana, Hiroyuki Hanzawa, Naoki Nakao, Giorgio Senaldi, Alexa B. Schrock, Russell Madison, Heather A. Wakelee, Thomas Yang Sun, Viola W. Zhu, Yuki Shimizu, Ryohei Katayama, Alice T. Shaw, Erkut Borazanci, Kyriakos P. Papadopoulos
Supplemental tables and figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47373f841d777bd84e2a008fd2ff0bf3
https://doi.org/10.1158/1078-0432.22475964.v1
https://doi.org/10.1158/1078-0432.22475964.v1
Autor:
Justin F. Gainor, Alexander Drilon, Aaron N. Hata, Sai-Hong Ignatius Ou, Michael S. Lawrence, Alice T. Shaw, Jochen K. Lennerz, Beow Y. Yeap, Lecia V. Sequist, Jennifer S. Temel, Christina J. Falcon, Adam J. Schoenfeld, Adam Langenbucher, Harper G. Hubbeling, Wafa Malik, Kylie Prutisto-Chang, Jennifer Peterson, Andrew Do, Charlotte Lee, Subba R. Digumarthy, Ibiayi Dagogo-Jack, Ramin Sakhtemani, Ted W. Johnson, Viola W. Zhu, Satoshi Yoda, Noura J. Choudhury, Jessica J. Lin
Supplementary methods, figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47e82d757e4978f6be4f2a06e2e25469
https://doi.org/10.1158/1078-0432.22478828
https://doi.org/10.1158/1078-0432.22478828
Autor:
Alice T. Shaw, Vlatka Smoljanovic, Peter N. Morcos, Walter Bordogna, Malgorzata Nowicka, Johannes Noé, Krzysztof Konopa, Sai-Hong Ignatius Ou, Shirish M. Gadgeel, D. Ross Camidge, Tony Mok, Solange Peters, Rafal Dziadziuszko
Supplementary Figure from Circulating Cell-free DNA as a Prognostic Biomarker in Patients with Advanced ALK+ Non–small Cell Lung Cancer in the Global Phase III ALEX Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2512b2f1811c705d7d3cf3523e86fe1a
https://doi.org/10.1158/1078-0432.22484165.v1
https://doi.org/10.1158/1078-0432.22484165.v1
Autor:
Alice T. Shaw, Vlatka Smoljanovic, Peter N. Morcos, Walter Bordogna, Malgorzata Nowicka, Johannes Noé, Krzysztof Konopa, Sai-Hong Ignatius Ou, Shirish M. Gadgeel, D. Ross Camidge, Tony Mok, Solange Peters, Rafal Dziadziuszko
Purpose:We retrospectively assessed prognostic value of circulating cell-free DNA (cfDNA) using data from the phase III ALEX study in treatment-naïve, advanced ALK+ non–small cell lung cancer (NSCLC).Patients and Methods:Patients were randomized t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9019549bd2a8bbe8cd724b0cef99fa93
https://doi.org/10.1158/1078-0432.c.6531344.v1
https://doi.org/10.1158/1078-0432.c.6531344.v1
Autor:
Justin F. Gainor, Alexander Drilon, Aaron N. Hata, Sai-Hong Ignatius Ou, Michael S. Lawrence, Alice T. Shaw, Jochen K. Lennerz, Beow Y. Yeap, Lecia V. Sequist, Jennifer S. Temel, Christina J. Falcon, Adam J. Schoenfeld, Adam Langenbucher, Harper G. Hubbeling, Wafa Malik, Kylie Prutisto-Chang, Jennifer Peterson, Andrew Do, Charlotte Lee, Subba R. Digumarthy, Ibiayi Dagogo-Jack, Ramin Sakhtemani, Ted W. Johnson, Viola W. Zhu, Satoshi Yoda, Noura J. Choudhury, Jessica J. Lin
Purpose:Current standard initial therapy for advanced, ROS proto-oncogene 1, receptor tyrosine kinase fusion (ROS1)-positive (ROS1+) non–small cell lung cancer (NSCLC) is crizotinib or entrectinib. Lorlatinib, a next-generation anaplastic lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5172c89aba121b65d81b64c96d23e465
https://doi.org/10.1158/1078-0432.c.6530057.v1
https://doi.org/10.1158/1078-0432.c.6530057.v1
Publikováno v:
Journal of Thoracic Oncology. 18:e57-e58
Autor:
Sai-Hong, Ignatius Ou
Publikováno v:
Journal of Thoracic Oncology. 17:e86-e88